Vaccines: Tackling the root cause of type 1 diabetes

By Thania Benios In the 19th and early 20th centuries, diphtheria, measles, and mumps were frightening household names. Each year in the United States, these illnesses struck hundreds of thousands of people, and claimed up to tens of thousands of lives. Children were especially vulnerable to the bacteria and viruses that led to such staggering […]

A Novel Way to Address Autoimmunity in Type 1 Diabetes

Researchers are developing a novel oral vaccine for type 1 diabetes. Using “yeast shells” to deliver proteins and other agents, the vaccine is intended to interrupt the immune attack that causes diabetes, as well as silence key genes that contribute to inflammation and autoimmunity.